Two multicenter Phase I randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Doxil® or Caelyx® in advanced ovarian cancer
Bhowmik, Shravanti, Bhowmick, Subhas, Maiti, Kuntal, Chakra, Amaresh, Shahi, Pradeep, Jain, Deepak, Rajamannar, ThennatiLanguage:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-018-3643-3
Date:
July, 2018
File:
PDF, 1.22 MB
english, 2018